Clinical Trial Update: Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy [Phase 4]

View source ↗

Summary

This clinical trial update discusses a Phase 4 study of clobazam as an adjunctive treatment for adults with refractory focal epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: Pavel Klein | Conditions: Epilepsy | Phase 4 | Status: UNKNOWN